feed,title,long_url,short_url
SeekingAlpha,Eli Lilly's mirikizumab meets primary endpoint in late-stage ulcerative colitis trial,https://seekingalpha.com/news/3780169,
SeekingAlpha,Notable earnings after Wednesday's close,https://seekingalpha.com/news/3779936,
SeekingAlpha,"SPLK, BNTX among after-hour movers",https://seekingalpha.com/news/3780168,
